Clinical Trial: Modification of Inhibitory Control and Craving Through tDCS as an Add-On Treatment for Substance Use Disorder

U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06959342) titled 'Modification of Inhibitory Control and Craving Through tDCS as an Add-On Treatment for Substance Use Disorder' on April 02.

Brief Summary: The aim of this project is to investigate the potential of transcranial direct current stimulation (tDCS) to reduce cognitive deficits and substance craving in individuals with substance use disorders (SUD), with a focus on alcohol use disorder (AUD). We are studying patients of any gender between the ages of 18 and 65 who are in our inpatient and day clinic settings for a standard detoxification treatment program. As there are conflicting findings regarding the effective settings for tDCS as an ad...